SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001363763-20-000001
Filing Date
2020-03-24
Accepted
2020-03-24 16:20:37
Documents
1
Period of Report
2020-03-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5524
  Complete submission text file 0001363763-20-000001.txt   7017
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Issuer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AURORA CAPITAL, LLC 17 PARK AVENUE, #201 NEW YORK NY 10016
Business Address
Lippa Arnold (Reporting) CIK: 0001363763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16467 | Film No.: 20738614